Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

How Biotech and Big Pharma Have Upside Heading Into Earnings

Posted: October 19, 2019 at 6:45 am

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Posted: October 18, 2019 at 9:00 am

Stocks were indicated to open marginally higher on Friday as earnings season is so far proving to be not as bad as many investors had modeled in for the third ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AIG, Aqua America, CenterPoint, Ferrari, GameStop, Medtronic, Roku, Salesforce, Uber and More

Posted: June 5, 2019 at 9:00 am

Stocks were indicated to open higher again after Tuesday's major rally. The markets still likely will be reacting daily to the ups and downs of the trade war and other ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Dover, Facebook, Lam Research, Newmont Mining, Occidental, Six Flags, Tesla, 3D Systems and More

Posted: April 22, 2019 at 8:55 am

Stocks were indicated to open lower on Monday after the Easter three-day weekend. With the major market indexes all still up well into the double-digit percentages year to date, both ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Arena Pharma, Autodesk, Coca-Cola, GE, Marvell, Monster Beverages, Nabors, Procter & Gamble and More

Posted: December 13, 2018 at 9:15 am

The futures traded slightly higher Thursday morning as the markets digested yesterday's upside move. Positive talk on trade and some more benign inflation data were seen as the key reasons ...
Read Full Story »

Wells Fargo, Neurocrine Drop into Wednesday’s 52-Week Low Club

Posted: December 12, 2018 at 4:02 pm

December 12, 2018: Here are four stocks trading with heavy volume among 243 equities making new 52-week lows Wednesday. On the NYSE, advancers led decliners by about 2.48 to 1 ...
Read Full Story »

Neurocrine Bio Stumbles on Tourette Study Results

Posted: December 12, 2018 at 11:15 am

Neurocrine Biosciences Inc. (NASDAQ: NBIX) shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations. Specifically, the firm announced topline ...
Read Full Story »

Stifel Has Red-Hot Biotech Stocks to Buy With Huge Upside Potential

Posted: September 21, 2018 at 8:45 am

Needless to say, the biotech world has had a volatile 18 months. Some of the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, are ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Posted: September 11, 2018 at 10:55 am

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Anthem, Constellation Brands, Hecla, Nike, Overstock.com, UnitedHealth and More

Posted: September 10, 2018 at 8:55 am

Stocks were indicated to open higher on Monday after a choppy prior week. Investors have seen less upside when they have bought the market pullbacks than in prior years, and investors ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS, Vertex and More

Posted: February 23, 2018 at 9:05 am

The stock market has demonstrated that perhaps the return of volatility is real after Wednesday's big gains suddenly turned into a big loss in the final 30 minutes of trading. ...
Read Full Story »